GoldenGolden
University of California, San Francisco

University of California, San Francisco

University

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Denise Chow and David Ingram
May 5, 2021
NBC News
San Francisco's low case numbers and high vaccination rates are signaling to experts that the city may have already reached herd immunity.
Heather Landi
May 4, 2021
FierceHealthcare
Wearables company Oura banked a $100 million series C funding round led by a diverse mix of healthcare, consumer and sports investors.
FinSMEs
May 4, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Conor Dougherty
April 17, 2021
www.nytimes.com
For homeless people, a place to live is life changing to a degree that almost no other intervention can provide.
Soner Sonmezoglu
March 29, 2021
Nature Biotechnology
Vascular complications following solid organ transplantation may lead to graft ischemia, dysfunction or loss. Imaging approaches can provide intermittent assessments of graft perfusion, but require highly skilled practitioners and do not directly assess graft oxygenation. Existing systems for monitoring tissue oxygenation are limited by the need for wired connections, the inability to provide real-time data or operation restricted to surface tissues. Here, we present a minimally invasive system to monitor deep-tissue O2 that reports continuous real-time data from centimeter-scale depths in sheep and up to a 10-cm depth in ex vivo porcine tissue. The system is composed of a millimeter-sized, wireless, ultrasound-powered implantable luminescence O2 sensor and an external transceiver for bidirectional data transfer, enabling deep-tissue oxygenation monitoring for surgical or critical care indications. The oxygenation of deep tissues is continuously measured using an ultrasound-powered wireless implant.
March 25, 2021
WebWire
Immunai, a New York and Tel Aviv-based biotech company, announced its acquisition of Dropprint Genomics, a San Francisco-based single-cell genomics software company. Immunai is also expanding its executive leadership team and scientific advisory board with experts in immunology, single-cell technologies and machine learning. Both the acquisition and new hires will advance the company's work in single cell functional genomics with the goal of better supporting discovery, prioritization, an...
Tina Reed
March 23, 2021
FierceHealthcare
Researchers from the University of California, San Francisco teamed with care coordination software company Careport Health to look at whether surges of patients at hospitals impacted patient outcomes. As it turned out, there was a clear difference.
BioSpace
December 1, 2020
BioSpace
FibroGen, Inc. (NASDAQ: FGEN) today announced the retirement of K. Peony Yu, M.D., Chief Medical Officer, and appointment of Mark Eisner, M.D., M.P.H. in that role. Dr. Yu will continue as Chief Medical Officer through December 20, 2020, the roxadustat PDUFA date, and will remain with FibroGen through March 15, 2021 serving as Executive Advisor to the CEO to support the transition. Dr. Yu joined FibroGen in 2008 and has provided key leadership
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.